Liver transplant bleeding study pulled before starting
Disease control
Terminated
This study was designed to see if a new clotting medicine works better than the standard one for controlling bleeding in liver transplant patients. It planned to include adults having a liver transplant who were at risk of bleeding problems. However, the study was withdrawn befor…
Phase: PHASE4 • Sponsor: Ezeldeen Abuelkasem • Aim: Disease control
Last updated May 26, 2026 11:54 UTC